Curriculum Vitae

 

Education

Dermatology Residency – Cook County Hospital – 7/79 – 6/82 Medical Residency – Harvard University – (Cambridge Hospital) – 6/78 – 6/79 Medical School  – Creighton University  – 7/74 – 6/78  (M.D.) Undergraduate Education – Johns Hopkins University – 8/71 – 5/74   (BA Natural Science)

Research Activities

Merck Sharp & Dome Corp. 5/75 – 9/75  (Atherosclerosis Research Division) National Cancer Institute – Baltimore Cancer Research Center – 8/72 – 4/74 Schering Plough Pharmaceutical Co. – 4/74 – 8/74  Steroid Synthesis Schering Plough Pharmaceutical Co. – 5/73 – 8/73  Antibiotic Synthesis Johns Hopkins University – 9/72 – 5/73  –  Delayed Bioluminescence

Publications

“Lichen Striatus with Onychodystrophy”,  Cutis, June, 1981, pp. 610 – 613 “Warty Dyskeratoma”, Cutis, January, 1982, pp. 78 – 81 Impact of Atopic Dermatitis Treatment on Parents’ Quality of Life: Results from Findings in Atopic Children with Eczema Study “Pharmacologic Doses of Nicotinamide in the Treatment  of Inflammatory Skin Conditions: A Review”, Cutis, January, 2006, Vol 77, No. 1S, pp. 11-16 “Nicomide Improvement in Clinical Outcomes Study (NICOS): Results of an 8 Week Trial” , Cutis, January, 2006, Vol 77,  No1S, pp. 17 – 28

pdf_icon.pngDr_Niren_A_Consummate_Professsional

pdf_icon.pngSkin_and_Hair_Maintenance

pdf_icon.pngABCs_of_Skin_Rejuvenation

Medical School Lectures

American University of the Caribbean 12/94 – present University of Pittsburgh – 7/82 – 12/92 Chicago Medical School – Weekly Lecture Series – 7/80 – 6/82 Tufts University School of Medicine 5/80 ,  9/81, 9/82, 9/83 International Society of Hair Restoration Society – Fall 1995 (Toronto, Canada) H&H Lecture Series Spring 1998 (Santa Fe, NM) Use of (microincision blades in hair transplantation)

Faculty Teaching Positions

American University of the Caribbean – 12/94 – present  (Clinical Instructor) University of Pittsburgh – 7/82 – 12/92  ( Assistant Clinical Professor)         1/99 – present – clinical instructor Chicago Medical School – 7/79 – 6/82 Cook County Hospital 7/79 – 6/82 Harvard University 7/78 – 7/79

Honor Societies

AED – Medical Honor Society

Medical Boards and Licenses Pennsylvania License    MD025703E Florida License   ME105156 American Society for Mohs Surgery – Board Certified – 3/98 Board Certified in Dermatology – 10/25/82 Voluntary Board Re-Certification by the American Board of Dermatology 6/15/09 and valid through 12/31/2019 Diplomat of the National Board of Medical Examiners – 3/79 FLEX Examination – passed 6/78 Medical Licenses in   PA (1981)  MA (1978)  IL (1979)  NE (1978)

Laser Experience

University of Pittsburgh (Passavant Hospital) Chairman of Laser committee 7/86 – 12-96 Operative Cutaneous Laser Surgery Workshop – Cleveland Clinic 10/86 Operative Cutaneous Laser Surgery Workshop – JUVA Skin Center – NYC – 1/2000

Professional Societies

American Society for Mohs Surgery 5/95 – present (fellow with annual voluntary review of cases) Pennsylvania Academy of Dermatology – 7/79 present American Academy of Dermatology 7/79 – present International Society of Dermatologic Surgery 1/93 – present International Society of Hair Restoration Surgery (charter member) 1/93 – present AMA 1978 – 1982 Illinois State Medical Society – 1979 -1982 Chicago Dermatologic Society – 1979 – 1982 Pittsburgh Academy of Dermatology 1982 – present

Advisory Boards – Medical Consultant

Schering Plough Pharmaceutical  – 1982 –1985 (advisory board) Lederle Pharmaceuticals  – (international division) 1983 –1988 (advisory board) Owen Pharmaceutical (Galderma Pharmaceutical) – 1982 – 1990 (advisory board) Medicis Pharmaceutical 1990 – present (advisory board) Allergan Pharmaceutical 1997 – present (advisory board, regional speaker) Novartis Pharmaceutical Phase III investigator for Lamisil  1996 – present (national speaker) Bristol Myer Squibb Phase III investigator for Tequin (antibiotic) 1999 – present Park Stone (Medical Information System) beta test site 1998 – Present Medicis Pharmaceutical – Loprox Clinical Trial 1999 – 2000 Vector Medical Corporation – (Transdermal medical delivery system – Advisory Board) 1999 – 2001 E-Corp., Inc (Executive Board) 5/96 – 1/99 Etoll, Inc. (Executive Board) 1/99 – 1/2002  Connetics Pharmaceutical Co – Phase III clinical trial on OLUX                                Clinical trial (blinded) on Dermsmoothe FS Oil vs Luxiq Novartis Pharmaceuticals – Phase III clinical trial on Elidel 2002 – present Galderma Pharmaceuticals – Phase III clinical trial on Triluma  9/2002 – 12/2002 Elan Pharmaceutical 1/2002 – Speakers Bureau Advisory Boards – Medical Consultant    (continued)

Glaxo Pharmaceutical 1/1990 – present Speakers Bureau Amgen Pharmaceutical 1/2002 present Speakers Bureau Novartis Pharmaceutical 1/1995 – present Speakers Bureau Aventis Pharmaceutical – Phase III clinical trial on Carac Crème, Efudex, PDT1/2001 – 6/2001 Galderma Pharmaceuticals – Triluma CLEAR Study – 5/04-9/04 Impact Network (Medical Information System) test site – 10/03 – Present Genentech – Control Trial Protocol ACD2782g – 10/03 – Present Amgen – Enbrel EDUCATE Study – 10/03 – Present Amgen – Enbrel EASE Study – 10/03 – Present Biogen – Amevive ATLAS Study – 4/04 – Present Galderma Pharmaceuticals – Differin Gel MORE Trial – 4/05 – Present

Free AAD Sponsored Skin Cancer Screenings

UPMC – Passavant Hospital  1982 – 2010  (annually) Suburban General – Allegheny University Hospital 1982 – 2005 (annually) Pittsburgh Pirates/Major League Baseball sponsored “Play It Smart” Screening 2004 – 2006

National Provider Identification Number 1508838061

UPIN # B33457